NCT06279130
- Conditions
- Resectable MMR-deficient Solid Tumors, Resectable MMR-proficient Solid Tumors
- Locations
-
- The Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
Clinical trial condition
Resectable MMR-proficient Solid Tumors
Explore clinical trials studying Resectable MMR-proficient Solid Tumors. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study